[91] similarly reported that HLA‐E mismatching was associated with reduced risk of bacterial infection post‐HCT (9.5% vs. 17.2%); however, conversely to other studies, they found an improvement to both aGvHD (7.7% vs. 12.3%) and cGvHD [91]. This evidence concerns the gene HLA-E and bacterial infectious disease.